3-year overall survival for patients with advanced NSCLC treated with pembrolizumab Meeting Abstract
| Authors: | Hellmann, M. D.; Leighl, N. B.; Hui, R.; Carcereny, E.; Felip, E.; Ahn, M. J.; Eder, J. P.; Balmanoukian, A. S.; Aggarwal, C.; Horn, L.; Patnaik, A.; Gubens, M. A.; Ramalingam, S. S.; Lubiniecki, G. M.; Zhang, J.; Piperdi, B.; Garon, E. B. |
| Abstract Title: | 3-year overall survival for patients with advanced NSCLC treated with pembrolizumab |
| Meeting Title: | COSA's 44th Annual Scientific Meeting |
| Journal Title: | Asia-Pacific Journal of Clinical Oncology |
| Volume: | 13 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Nov 13-15 |
| Meeting Location: | Sydney, Australia |
| ISSN: | 1743-7555 |
| Publisher: | Wiley Blackwell |
| Date Published: | 2017-11-01 |
| Start Page: | 60 |
| End Page: | 61 |
| Language: | English |
| ACCESSION: | WOS:000413954500003 |
| PROVIDER: | wos |
| PUBMED: | 29082610 |
| DOI: | 10.1111/ajco.12798 |
| Notes: | Meeting Abstract: 2 -- Source: Wos |
